Combined Oral Contraceptive – Oestrogen and Progestogen

Warning

Monophasic Low Strength Combined Oral Contraceptive

Preferred list (P)

GEDAREL 20/150®

  • Ethinylestradiol20 microgram
  • Desogestrel150 microgram

Total list (T)

MILLINETTE 20/75®

  • Ethinylestradiol20 microgram
  • Gestodene75 microgram

Monophasic Standard Strength Combined Oral Contraceptive

Preferred list (P)

RIGEVIDON®

  • Ethinylestradiol 30 microgram
  • Levonorgestrel 150 microgram

Total list (T)

GEDAREL 30/150®

  • Ethinylestradiol 30 microgram
  • Desogestrel 150 microgram

MILLINETTE 30/75®

  • Ethinylestradiol 30 microgram
  • Gestodene 75 microgram

CILIQUE®

  • Ethinylestradiol 35 microgram
  • Norgestimate 250 microgram

DRETINE®

  • Drospirenone 3 mg
  • Ethinylestradiol 30 microgram

NHSL Joint Adult Formulary Key

To indicate the category of a formulary medicine, updated sections adopt the following key:

Preferred list (P): First-line formulary choices.

Total list (T): Alternative choices when preferred list options not effective/not tolerated, or not indicated.

Specialist initiation (S1): Specialist initiation, or on the advice of a Consultant or Specialist Practitioner in this therapeutic area. Continuation in primary care is acceptable.

Specialist use only (S2): Supply via hospital, Homecare Service or a hospital based prescription (HBP) for dispensing by community pharmacy. Not prescribed in primary care setting.

Editorial Information

Last reviewed: 31/01/2022

Next review date: 31/01/2025

Author(s): NHSL.

Version: Please refer to the introduction section for an explanation of the review dates above.

Approved By: ADTC

Reviewer name(s): ADTC.